Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $51.5600 (-0.65%) ($51.5600 - $51.8600) on Tue. Feb. 7, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.48% (three month average) | RSI | 44 | Latest Price | $51.5600(-0.65%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | HALO advances 0.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) XBI(42%) IBB(41%) IFRA(40%) IWO(36%) IWM(35%) | Factors Impacting HALO price | HALO will decline at least -1.24% in a week (0% probabilities). VXX(-16%) VIXM(-13%) UUP(-11%) GLD(-9%) BND(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.24% (StdDev 2.48%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $51.83 | 5 Day Moving Average | $52.17(-1.17%) | 10 Day Moving Average | $52(-0.85%) | 20 Day Moving Average | $51.83(-0.52%) | To recent high | -13.1% | To recent low | 12.7% | Market Cap | $7.047b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |